Synonyms: M70 | NGM-282 | NGM282
Compound class:
Peptide
Comment: Aldafermin (NGM282) is a recombinant, engineered analogue of FGF-19 (FGF19-mimetic) that was developed by NGM Biopharmaceuticals. Acting via the FGFR4-β-Klotho (KLB) receptor complex, aldafermin acts to suppress cholesterol 7α-hydroxylase (CYP7A1), the first and rate-limiting enzyme for bile acids biosynthesis.
|
Classification ![]() |
|
Compound class | Peptide |
International Nonproprietary Names ![]() |
|
INN number | INN |
10948 | aldafermin |
Synonyms ![]() |
M70 | NGM-282 | NGM282 |
Database Links ![]() |
|
GtoPdb PubChem SID | 441604918 |
Search PubMed clinical trials | aldafermin |
Search PubMed titles | aldafermin |
Search PubMed titles/abstracts | aldafermin |